In parallel, treatment of the tumor cells by i-Ras also led to a reduction of their extracellular levels: 35–40%, 90–95% and 75–85% inhibition of CXCL8, CCL2 and CCL5, respectively. The gene discussed is CCL5; the disease is neoplasm.